Mutation and structure guided discovery of an antiviral small molecule that mimics an essential C‐Terminal tripeptide of the vaccinia D4 processivity factor

[1]  D. Hruby,et al.  Oral Tecovirimat for the Treatment of Smallpox , 2018, The New England journal of medicine.

[2]  M. Maccoss,et al.  Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers. , 2017, Journal of medicinal chemistry.

[3]  P. Traktman,et al.  The vaccinia virus DNA polymerase and its processivity factor. , 2017, Virus research.

[4]  R. Ricciardi,et al.  A Conserved Tripeptide Sequence at the C Terminus of the Poxvirus DNA Processivity Factor D4 Is Essential for Protein Integrity and Function* , 2016, The Journal of Biological Chemistry.

[5]  A. Gibbs,et al.  Elements and modulation of functional dynamics. , 2014, Journal of medicinal chemistry.

[6]  A. Nitsche,et al.  Genome-Wide Comparison of Cowpox Viruses Reveals a New Clade Related to Variola Virus , 2013, PloS one.

[7]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[8]  R. Ricciardi,et al.  Design of potent poxvirus inhibitors of the heterodimeric processivity factor required for viral replication. , 2013, Journal of medicinal chemistry.

[9]  Peter M. Kasson,et al.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..

[10]  James W. Noah,et al.  Identification of Protein-Protein Interaction Inhibitors Targeting Vaccinia Virus Processivity Factor for Development of Antiviral Agents , 2011, Antimicrobial Agents and Chemotherapy.

[11]  Matteo Floris,et al.  Swimming into peptidomimetic chemical space using pepMMsMIMIC , 2011, Nucleic Acids Res..

[12]  Kathleen A. Boyle,et al.  Evaluation of the Role of the Vaccinia Virus Uracil DNA Glycosylase and A20 Proteins as Intrinsic Components of the DNA Polymerase Holoenzyme* , 2011, The Journal of Biological Chemistry.

[13]  N. Schormann,et al.  Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4. , 2011, Journal of medicinal chemistry.

[14]  R. Ricciardi,et al.  Vaccinia Virus D4 Mutants Defective in Processive DNA Synthesis Retain Binding to A20 and DNA , 2010, Journal of Virology.

[15]  G. Andrei,et al.  Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection. , 2010, IDrugs : the investigational drugs journal.

[16]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[17]  J. Pelletier,et al.  Target identification using drug affinity responsive target stability (DARTS) , 2009, Proceedings of the National Academy of Sciences.

[18]  P. Callis,et al.  Solvent effects on the fluorescence quenching of tryptophan by amides via electron transfer. Experimental and computational studies. , 2009, The journal of physical chemistry. B.

[19]  R. Shoemaker,et al.  Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach. , 2008, Antiviral research.

[20]  R. Ricciardi,et al.  Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening. , 2008, Journal of medicinal chemistry.

[21]  Piotras Cimmperman,et al.  A quantitative model of thermal stabilization and destabilization of proteins by ligands. , 2008, Biophysical journal.

[22]  R. Jordan,et al.  N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors. , 2007, Journal of medicinal chemistry.

[23]  Joshua M. Epstein,et al.  Containing a large bioterrorist smallpox attack: a computer simulation approach. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[24]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[25]  E. Stanitsa,et al.  Vaccinia Virus Uracil DNA Glycosylase Interacts with the A20 Protein to Form a Heterodimeric Processivity Factor for the Viral DNA Polymerase* , 2006, Journal of Biological Chemistry.

[26]  R. Jordan,et al.  An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge , 2005, Journal of Virology.

[27]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[28]  E. De Clercq.  Cidofovir in the treatment of poxvirus infections , 2002, Antiviral research.

[29]  T. Härd,et al.  The N-terminal Regions of Estrogen Receptor α and β Are Unstructured in Vitro and Show Different TBP Binding Properties* , 2001, The Journal of Biological Chemistry.

[30]  B. Stillman,et al.  Opening of the Clamp An Intimate View of an ATP-Driven Biological Machine , 2001, Cell.

[31]  H. Dyson,et al.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.

[32]  D. Jabs,et al.  Incidence of Foscarnet Resistance and Cidofovir Resistance in Patients Treated for Cytomegalovirus Retinitis , 1998, Antimicrobial Agents and Chemotherapy.

[33]  A. Delange,et al.  The vaccinia virus-encoded uracil DNA glycosylase has an essential role in viral DNA replication. , 1994, Virology.

[34]  C Upton,et al.  Identification of a poxvirus gene encoding a uracil DNA glycosylase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. McFadden,et al.  A poxvirus-encoded uracil DNA glycosylase is essential for virus viability , 1993, Journal of virology.

[36]  G. Smith,et al.  Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. , 1992, The Journal of general virology.

[37]  R. Cowgill.  Fluorescence and protein structure. XVII. On the mechanism of peptide quenching. , 1970, Biochimica et biophysica acta.

[38]  R. Shoemaker,et al.  Rapid screening of chemical inhibitors that block processive DNA synthesis of herpesviruses: potential application to high-throughput screening. , 2005, Methods in molecular biology.

[39]  P. Kellam,et al.  Poxvirus genomes: a phylogenetic analysis. , 2004, The Journal of general virology.

[40]  F. Fenner.  Smallpox and its eradication , 1988 .